Jiangsu Hansoh Pharmaceutical Co., Ltd.
Clinical trials sponsored by Jiangsu Hansoh Pharmaceutical Co., Ltd., explained in plain language.
-
New hope for PNH patients: experimental drug HS-10542 enters human trials
Disease control Recruiting nowThis study tests a new drug called HS-10542 in adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder that destroys red blood cells. The goal is to see if the drug can safely raise hemoglobin levels and reduce the need for blood transfusions. About 50 partic…
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New lung cancer pill targets resistant mutations in early trial
Disease control Recruiting nowThis Phase 1 study tests a new daily pill called HS-10504 in 230 people with advanced non-small cell lung cancer that has a specific genetic change (EGFR C797S mutation) and has stopped responding to earlier treatments. The main goal is to find the safest dose and check for side …
Phase: PHASE1 • Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 26, 2026 18:26 UTC